2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Рекомендации Американской тиреоидной ассоциации 2015 года по ведению взрослых пациентов с узлами щитовидной железы и дифференцированным раком щитовидной железы: рабочая группа Американской тиреоидной ассоциации по рекомендациям для пациентов с узлами щитовидной железы и дифференцированным раком щитовидной железы
2015-10-14
SCID: 54.1/ky48yaa6
Discuss with AI
differentiated thyroid cancerfine-needle aspiration biopsymolecular markersradioiodine remnant ablationthyroid nodules
Figures from the paper
Abstract (AI)
BACKGROUND: Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Since the American Thyroid Association's (ATA's) guidelines for the management of these disorders were revised in 2009, significant scientific advances have occurred in the field. The aim of these guidelines is to inform clinicians, patients, researchers, and health policy makers on published evidence relating to the diagnosis and management of thyroid nodules and differentiated thyroid cancer. METHODS: The specific clinical questions addressed in these guidelines were based on prior versions of the guidelines, stakeholder input, and input of task force members. Task force panel members were educated on knowledge synthesis methods, including electronic database searching, review and selection of relevant citations, and critical appraisal of selected studies. Published English language articles on adults were eligible for inclusion. The American College of Physicians Guideline Grading System was used for critical appraisal of evidence and grading strength of recommendations for therapeutic interventions. We developed a similarly formatted system to appraise the quality of such studies and resultant recommendations. The guideline panel had complete editorial independence from the ATA. Competing interests of guideline task force members were regularly updated, managed, and communicated to the ATA and task force members. RESULTS: The revised guidelines for the management of thyroid nodules include recommendations regarding initial evaluation, clinical and ultrasound criteria for fine-needle aspiration biopsy, interpretation of fine-needle aspiration biopsy results, use of molecular markers, and management of benign thyroid nodules. Recommendations regarding the initial management of thyroid cancer include those relating to screening for thyroid cancer, staging and risk assessment, surgical management, radioiodine remnant ablation and therapy, and thyrotropin suppression therapy using levothyroxine. Recommendations related to long-term management of differentiated thyroid cancer include those related to surveillance for recurrent disease using imaging and serum thyroglobulin, thyroid hormone therapy, management of recurrent and metastatic disease, consideration for clinical trials and targeted therapy, as well as directions for future research. CONCLUSIONS: We have developed evidence-based recommendations to inform clinical decision-making in the management of thyroid nodules and differentiated thyroid cancer. They represent, in our opinion, contemporary optimal care for patients with these disorders.
Key Findings
1
For differentiated thyroid cancer, the guidelines address screening, staging and risk assessment, surgery, and radioiodine remnant ablation and therapy.
2
Recommendations were developed through systematic literature searching, critical appraisal, and evidence grading, with complete editorial independence from the ATA and managed disclosure of competing interests.
3
The guidelines incorporate published evidence on adults and were designed to inform clinicians, patients, researchers, and health policymakers.
4
The guidelines update the 2009 American Thyroid Association recommendations in response to significant advances in thyroid nodule and differentiated thyroid cancer research.
5
They provide evidence-based recommendations for initial thyroid nodule evaluation, ultrasound and clinical criteria for fine-needle aspiration, cytology interpretation, molecular markers, and benign nodule management.
Research Object
Adult patients with thyroid nodules and differentiated thyroid cancer
Research Subject
Evidence-based diagnosis, risk assessment, and management of thyroid nodules and differentiated thyroid cancer
Publication Details
Publication Date
2015-10-14
Journal
Publisher
ISSN
Cited by
16710
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai2
Cited by9
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries2024
Cancer treatment and survivorship statistics, 20222022
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis2016
Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules2018
Cancer treatment and survivorship statistics, 20252025
Current State and Future Perspective of Molecular Diagnosis of Fine-Needle Aspiration Biopsy of Thyroid Nodules2011
Molecular Classification of Thyroid Nodules with Indeterminate Cytology: Development and Validation of a Highly Sensitive and Specific New miRNA-Based Classifier Test Using Fine-Needle Aspiration Smear Slides2018
Annotation-Free Deep Learning-Based Prediction of Thyroid Molecular Cancer Biomarker BRAF (V600E) from Cytological Slides2023
Thyroid cytology smear slides: An untapped resource for ThyroSeq testing2020